Your browser doesn't support javascript.
loading
TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab.
Isoda, Bunpei; Kandori, Shuya; Sazuka, Tomokazu; Kojima, Takahiro; Nitta, Satoshi; Shiga, Masanobu; Nagumo, Yoshiyuki; Fujimoto, Ayumi; Arai, Takayuki; Sato, Hiroaki; Mathis, Bryan J; Wu, Chia-Ling; Jan, Yi-Hua; Ichikawa, Tomohiko; Nishiyama, Hiroyuki.
Affiliation
  • Isoda B; Department of Urology, Institute of Medicine, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
  • Kandori S; Department of Urology, Institute of Medicine, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
  • Sazuka T; Department of Urology, Graduate School of Medicine, Chiba University, Chiba 263-8522, Chiba, Japan.
  • Kojima T; Department of Urology, Aichi Cancer Center, Nagoya 464-8681, Aichi, Japan.
  • Nitta S; Department of Urology, Institute of Medicine, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
  • Shiga M; Department of Urology, Institute of Medicine, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
  • Nagumo Y; Department of Urology, Institute of Medicine, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
  • Fujimoto A; Department of Urology, Graduate School of Medicine, Chiba University, Chiba 263-8522, Chiba, Japan.
  • Arai T; Department of Urology, Graduate School of Medicine, Chiba University, Chiba 263-8522, Chiba, Japan.
  • Sato H; Department of Urology, Graduate School of Medicine, Chiba University, Chiba 263-8522, Chiba, Japan.
  • Mathis BJ; International Medical Center, University of Tsukuba Affiliated Hospital, Tsukuba 305-8576, Ibaraki, Japan.
  • Wu CL; ACT Genomics, Co., Ltd., Taipei 114, Taiwan.
  • Jan YH; ACT Genomics, Co., Ltd., Taipei 114, Taiwan.
  • Ichikawa T; Department of Urology, Graduate School of Medicine, Chiba University, Chiba 263-8522, Chiba, Japan.
  • Nishiyama H; Department of Urology, Institute of Medicine, University of Tsukuba, Tsukuba 305-8577, Ibaraki, Japan.
Int J Mol Sci ; 25(13)2024 Jul 06.
Article in En | MEDLINE | ID: mdl-39000552
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Tumor Microenvironment / Ipilimumab / Nivolumab / Kidney Neoplasms Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Tumor Microenvironment / Ipilimumab / Nivolumab / Kidney Neoplasms Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2024 Document type: Article Affiliation country: Japón Country of publication: Suiza